FDx Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-9,562
| Closed | -$388K | – | 631 |
|
|
2019
Q2 | $388K | Sell |
9,562
-366
| -4% | -$14.9K | 0.02% | 548 |
|
|
2019
Q1 | $300K | Buy |
+9,928
| New | +$300K | 0.01% | 600 |
|
|
2018
Q4 | – | Sell |
-11,221
| Closed | -$473K | – | 558 |
|
|
2018
Q3 | $473K | Buy |
11,221
+3,016
| +37% | +$127K | 0.02% | 538 |
|
|
2018
Q2 | $263K | Buy |
8,205
+1,253
| +18% | +$40.2K | 0.01% | 769 |
|
|
2018
Q1 | $346K | Sell |
6,952
-9
| -0.1% | -$448 | 0.01% | 914 |
|
|
2017
Q4 | $375K | Sell |
6,961
-52
| -0.7% | -$2.8K | 0.01% | 920 |
|
|
2017
Q3 | $407K | Buy |
7,013
+1,401
| +25% | +$81.3K | 0.01% | 897 |
|
|
2017
Q2 | $277K | Buy |
5,612
+527
| +10% | +$26K | 0.01% | 1014 |
|
|
2017
Q1 | $221K | Buy |
+5,085
| New | +$221K | 0.01% | 1085 |
|